These spring quotes will warm your heart after a long, cold winter Spring quotes that will banish the winter blues Every ...

HUBBARD, Ohio (WKBN) — Lily Walter often looks for books at the Hubbard Public Library. She got her first library card at age 4. Today, she’s 104. “Sometimes it’s the title that intrigues ...

HUBBARD, Ohio (WKBN) – Lily Walter often looks for books at the Hubbard Public Library. She got her first library card at age 4. Today, she’s 104. “Sometimes it’s the title that intrigues ...

Eli Lilly is buying a new drug and lowering prices on an existing one. GLP-1 weight loss drug Zepbound is getting cheaper. This will make Lilly's product relatively more attractive, and help to ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...

Eli Lilly stock has advanced more than 200% over the past three years thanks to the company’s dominance in the weight loss drug market. Lilly may face more competitors down the road in this high ...

Eli Lilly and Co. Wednesday announced plans to build four pharmaceutical manufacturing sites in the United States, significantly boosting domestic medicine production and adding around 13,000 ...

Eli Lilly LLY.N plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a Washington press conference on Wednesday, as it grapples with the ...

Eli Lilly is unleashing new ammunition in its fight against cheaper, compounded versions of its obesity blockbuster Zepbound. The Indiana-based drugmaker is slashing the prices of its 2.5 mg ...

Regarding weight loss, Lilly in June 2023 unveiled phase 2 data showing orforglipron helped patients with obesity lose up to 14.7% of their body weight at 36 weeks compared to placebo. While those ...

Julie Ann Kenney Walters, beloved wife, mother, daughter, sister, and friend left us much too soon on February 6, 2025 in Irvine, California, surrounded by loved ones. Born in 1981 in Orange ...

Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a deal worth up to $50 million in biobucks. Organovo’s stock ...